The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
ObjectivesTo determine if men with adverse pathology but undetectable ultrasensitive (<0.01 ng/mL) PSA are at high‐risk for biochemical recurrence (BCR), or if there is a subset of patients at low‐risk for whom the benefit of adjuvant radiation therapy might be limited.
Patients and MethodsWe evaluated 411 patients treated with RP from 2001 to 2013 without adjuvant radiation who had an undetectable...
ObjectiveTo assess the impact of positive surgical margins (PSMs) on long‐term outcomes after radical prostatectomy (RP), including metastasis, castrate‐resistant prostate cancer (CRPC), and prostate cancer‐specific mortality (PCSM).
Patients and MethodsRetrospective study of 4 051 men in the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort treated by RP from 1988 to 2013. Proportional...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.